PLA2G3 anticorps (Internal Region)

N° du produit ABIN2469549

Cet anticorps anti-PLA2G3 Polyclonal Lapin (ABIN2469549) détecte spécifiquement PLA2G3 dans IHC. L’anticorps est réactif avec des échantillons de Humain, Boeuf (Vache), Singe, Porc, Gibbon et Gorilla.

Aperçu rapide pour PLA2G3 anticorps (Internal Region) (ABIN2469549)

Antigène: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Reactivité: Humain, Boeuf (Vache), Singe, Porc, Gibbon, Gorilla

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G3 est non-conjugé

Application: Immunohistochemistry (IHC)

Détail du produit anti-PLA2G3 anticorps

Épitope: Internal Region

Specificité: BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Purification: Immunoaffinity Chromatography

Immunogène: PLA2G3 antibody was raised against a peptide located near the internal domain of PLA2G3 (Human).

Information d'application

Indications d'application: PLA2G3 antibody can be used in ELISA, and immunohistochemistry starting at 10 μg/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, 0.1 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: As with all antibodies avoid freeze/thaw cycles.

Stock: 4 °C/-80 °C

Stockage commentaire: PLA2G3 antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.

Détails sur PLA2G3

Antigène: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Autre désignation: PLA2G3

Sujet: Human group III secreted phospholipase A2 belongs to a superfamily of intracellular and secreted enzymes that catalyze the hydrolysis of glycerophospholipids at the sn-2 position to release fatty acids and lysophospholipids. Group III PLA2 enzymes were originally identified in invertebrates such as bees and scorpions. Human group III sPLA2 has been shown to be a calcium dependent enzyme. It consists of a central group III sPLA2 domain flanked by unique N- and C-terminal domains that are proteolytically removed in most tissues. The sPLA2 domain is sufficient for catalytic activity. SPLA2-III is preferentially expressed in the microvascular endothelium of tissues with inflammation, ischemic injury and cancer.

ID gène: 50487

UniProt: Q9NZ20